Brief: Astrazeneca Pharma India Gets Notice Of Demand From National Pharmaceutical Pricing Authority
29/06/2021 13:34
June 29 (Reuters) - Astrazeneca Pharma India Ltd ASTR.NS :
* ASTRAZENECA PHARMA INDIA SAYS GETS NOTICE OF DEMAND FROM
NATIONAL PHARMACEUTICAL PRICING AUTHORITY FOR TAGRISSO TABLETS
* ASTRAZENECA PHARMA INDIA SAYS NOTICE OF DEMAND ALLEGES
THAT CO
HAS OVERCHARGED 1.57 BILLION RUPEES DURING MARCH 2019-JAN 2021
* ASTRAZENECA PHARMA INDIA SAYS CO ORDERED TO DEPOSIT 1.57
BILLION
RUPEES WITHIN 30 DAYS FROM JUNE 25
* ASTRAZENECA PHARMA INDIA SAYS NOTICE ALSO PENALISES CO FOR
ACCOUNTING ERRORS OF DRUGS SUPPLIED TO GOVERNMENT INSTITUTIONS
* ASTRAZENECA PHARMA INDIA SAYS CO HAS FILED WRIT PETITION
BEFORE
DELHI HIGH COURT CHALLENGING DEMAND NOTICE
Source text for Eikon: ID:nBSE3bx93n
Further company coverage: ASTR.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Astrazeneca Pharma India
See all newsBrief: Astrazeneca Pharma Gets Permission To Import For Sale Of Trastuzumab Deruxtecan
India's Astrazeneca Pharma logs worst slide in two months on quarterly profit drop
Brief: Astrazeneca Pharma India March-Quarter PAT 448.8 Million Rupees
Brief: Astrazeneca Pharma India Recommends Dividend Of 36 Rupees Per Equity Share For Fy2025-26
Brief: Astrazeneca Pharma India Receives Permission To Import Durvalumab (Imfinzi) For Additional Indication